While the effects of metformin on GDF15 are important for the weight-lowering effects of the drug—and those effects contribute significantly to the ability of metformin to prevent the onset of T2DM in at-risk individuals—metformin has effects on lowering glucose and insulin that are independent of GDF15-GFRAL signaling3. This evidence concerns the gene INS and type 2 diabetes mellitus.